相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cervical Spine Computed Tomography Hounsfield Units Accurately Predict Low Bone Mineral Density of the Femoral Neck
Donald F. Colantonio et al.
CLINICAL SPINE SURGERY (2020)
Measurement Techniques and Utility of Hounsfield Unit Values for Assessment of Bone Quality Prior to Spinal Instrumentation A Review of Current Literature
Qasim Zaidi et al.
SPINE (2019)
Bone Health Optimization: Beyond Own the Bone AOA Critical Issues
Paul A. Anderson et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2019)
Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE
R. Eastell et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Teriparatide treatment exerts differential effects on the central and peripheral skeleton: results from the MOAT study
M. A. Paggiosi et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass
Harry K. Genant et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Retrospective radiological outcome analysis following teriparatide use in elderly patients undergoing multilevel instrumented lumbar fusion surgery
Arun-Kumar Kaliya-Perumal et al.
MEDICINE (2017)
Evidence for Use of Teriparatide in Spinal Fusion Surgery in Osteoporotic Patients
Navjot Chaudhary et al.
WORLD NEUROSURGERY (2017)
Opportunistic screening for osteoporosis using the sagittal reconstruction from routine abdominal CT for combined assessment of vertebral fractures and density
S. J. Lee et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Teriparatide improves volumetric bone mineral density and fine bone structure in the UIV+1 vertebra, and reduces bone failure type PJK after surgery for adult spinal deformity
M. Yagi et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Diagnosing the Undiagnosed: Osteoporosis in Patients Undergoing Lumbar Fusion
Scott C. Wagner et al.
SPINE (2016)
Trabecular Bone Score in Patients With Chronic Glucocorticoid Therapy-Induced Osteoporosis Treated With Alendronate or Teriparatide
Kenneth G. Saag et al.
ARTHRITIS & RHEUMATOLOGY (2016)
A Systematic Review of Treatment Strategies for Degenerative Lumbar Spine Fusion Surgery in Patients With Osteoporosis
Charla R. Fischer et al.
GERIATRIC ORTHOPAEDIC SURGERY & REHABILITATION (2016)
Assessing the Effects of Teriparatide Treatment on Bone Mineral Density, Bone Microarchitecture, and Bone Strength
Michael Kleerekoper et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2014)
Teriparatide increases the insertional torque of pedicle screws during fusion surgery in patients with postmenopausal osteoporosis
Gen Inoue et al.
JOURNAL OF NEUROSURGERY-SPINE (2014)
Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study
C. Senn et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Opportunistic Screening for Osteoporosis Using Abdominal Computed Tomography Scans Obtained for Other Indications
Perry J. Pickhardt et al.
ANNALS OF INTERNAL MEDICINE (2013)
Comparison of Teriparatide and Bisphosphonate Treatment to Reduce Pedicle Screw Loosening After Lumbar Spinal Fusion Surgery in Postmenopausal Women With Osteoporosis From a Bone Quality Perspective
Seiji Ohtori et al.
SPINE (2013)
Teriparatide Accelerates Lumbar Posterolateral Fusion in Women With Postmenopausal Osteoporosis Prospective Study
Seiji Ohtori et al.
SPINE (2012)
Hounsfield Units for Assessing Bone Mineral Density and Strength: A Tool for Osteoporosis Management
Joseph J. Schreiber et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2011)
Osteoporosis in Men: Update 2011
Denise L. Orwig et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2011)
Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-Month, randomized, placebo-controlled, double-blind and 12-month open-label phases
Akimitsu Miyauchi et al.
BONE (2010)
Osteoporosis in Men: What has Changed?
Robert A. Adler
Current Osteoporosis Reports (2010)
Sequential Treatment of Severe Postmenopausal Osteoporosis After Teriparatide: Final Results of the Randomized, Controlled European Study of Forsteo (EUROFORS)
Richard Eastell et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Effects of Teriparatide Treatment and Discontinuation in Postmenopausal Women and Eugonadal Men with Osteoporosis
Benjamin Z. Leder et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment
Barbara M. Obermayer-Pietsch et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Prevalence of osteoporosis in patients requiring spine surgery: incidence and significance of osteoporosis in spine disease
D. K. Chin et al.
OSTEOPOROSIS INTERNATIONAL (2007)
Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass
MR McClung et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
The importance of bisphosphonate therapy mass in men after therapy with teriparatide [human parathyroid hormone(1-34)]
ES Kurland et al.
OSTEOPOROSIS INTERNATIONAL (2004)
Recombinant human parathyroid hormone (1-34) [Teriparatide] improves both cortical and cancellous bone structure
YB Jiang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
分享论文
